Emotions, as well as function, determine MD trust: study

Emotions, as well as function, determine MD trust: study
Emotions, as well as function, determine MD trust: study

Physician trust in pharmaceutical brands is driven by an emotional connection as well as functional attributes and perceptions of the manufacturer, said Harris Interactive, which found doctors gave Advair, Spiriva and Mirena top marks.

The firm queried physicians about branded drugs for asthma, COPD, osteoporosis, contraception and rheumatoid arthritis based on five measures of trust, including the product's familiarity, function and connection.

Joseph Vorassi, SVP healthcare research at Harris Interactive told MM&M that the components of each measurement break down as follows:  “For function, it's offering unique benefits, excellent outcomes and consistent results. On the connection, being able to identify with the product… On the rep side, it's being respectful of staff, being responsive, providing unbiased info.”

The most-trusted brands in the categories polled:

Asthma: Advair, followed by Symbicort

COPD: Spiriva, then Advair, Symbicort and Combivent

Osteoporosis:  Actonel, followed by Evista, Forteo, Prolia and Reclast

Contraception: Mirena, followed by NuvaRing, Lo LoEstrin and Depo-Provera

Rheumatoid Arthritis: Enbrel and Humira tied for first, followed by Remicade, Orencia and Rituxan
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.